Scemblix 100 MG tablet UU 60S
Ended Awarded Last action
- Contract number
- SPE2DR26FCZ7N
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,640
Award facts
- Contract value 100% obligated
- $15,640.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (UEI: KABZK8W6PQT3) on January 14, 2026, for the supply of Scemblix 100 mg tablets in quantities of 60 units. This firm fixed-price delivery order, valued at $15,640.25, represents a non-competitive award under the company's existing pharmaceutical supply contract with DLA. The product will be delivered to the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of February 5, 2026. Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as a critical vendor within the federal pharmaceutical supply chain and is registered in the System for Award Management (SAM.gov).
This delivery order is issued under a larger Indefinite Delivery Contract vehicle with the DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This comprehensive pharmaceutical contract enables Amerisourcebergen Drug Corp to supply a vast array of medications, vaccines, and medical supplies to support military healthcare programs globally, including services to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The supply of Scemblix, a specialty medication used in oncology treatment, reflects the company's role in delivering brand-name and generic pharmaceuticals across multiple therapeutic domains to federal military and healthcare institutions.
Quick answers
Who was awarded contract SPE2DR26FCZ7N?
SPE2DR26FCZ7N was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 14, 2026.
How much is contract SPE2DR26FCZ7N worth?
The government has obligated $15,640 on SPE2DR26FCZ7N.
Is contract SPE2DR26FCZ7N an order under another contract?
Yes. SPE2DR26FCZ7N is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCZ7N competed?
The extent of competition for SPE2DR26FCZ7N was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award